Q2 saw 9.2% sales growth to SEK 247 million, with all business areas contributing and adjusted operating margin at 5.8%. Strategic investments and the KNXT acquisition impacted cash flow, but the company remains well-positioned for growth in expanding nuclear markets.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.